---
title: "Telix Pharmaceuticals (TLX.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/TLX.US/norm.md"
symbol: "TLX.US"
name: "Telix Pharmaceuticals"
parent: "https://longbridge.com/zh-CN/quote/TLX.US.md"
datetime: "2026-05-20T00:28:51.947Z"
locales:
  - [en](https://longbridge.com/en/quote/TLX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TLX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TLX.US/norm.md)
---

# Telix Pharmaceuticals (TLX.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0083 | -0.0083 | -0.0034 | -0.0034 | 0.0387 |
| ROE | -2.33% | -2.31% | -1.09% | -1.18% | 7.99% |
| 营业收入 | 206.72M | 206.72M | 195.18M | 195.18M | 138.47M |
| 净利润 | -2.42M | -2.42M | -1.15M | -1.15M | 7.05M |
| 营业利润 | 4.02M | 4.02M | 5.63M | 5.63M | 13.08M |
| 毛利率 | 46.46% | 46.46% | 48.62% | 48.62% | 61.64% |
| 净利率 | -1.17% | -1.17% | -0.59% | -0.59% | 5.09% |
| 利润含金量 | -22.94% | -22.94% | 63.38% | 63.38% | 629.22% |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 1.16B | 1.16B | 1.19B | 1.19B | 940.38M |
| 权益乘数 | 2.80 | 2.80 | 2.82 | 2.82 | 2.66 |
| 每股净资产 | 1.23 | 1.23 | 1.25 | 1.25 | 1.05 |
| 资产周转率 | 0.7639 | 0.6991 | 0.7872 | 0.7880 | 0.8484 |
| 现金及短投 | 141.87M | 141.87M | 207.16M | 207.16M | 440.00M |
| 存货与应收 | 37.08M | 37.08M | 35.23M | 35.23M | 23.62M |
| 长期投资 | 115.61M | 115.61M | 74.18M | 74.18M | 33.65M |
| 净债务 | 325.24M | 325.24M | 211.10M | 211.10M | -79.84M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -17.52M | -17.52M | 8.87M | 8.87M | 2.08M |
| 投资现金流 | -13.53M | -13.53M | -129.43M | -129.43M | -28.13M |
| 融资现金流 | -398000.00 | -398000.00 | -1.46M | -1.46M | 207.68M |
| 自由现金流 | 2.31M | -59.80M | 2.21M | 25.75M | 7.08M |
| 现金流充裕率 | -163.13% | -163.13% | 172.87% | 172.87% | 56.76% |
| 举债与偿债 | 264500.00 | 264500.00 | - | - | 213.06M |
| 资本支出 | -9.51M | -9.51M | -3.33M | -3.33M | -3.02M |